The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy
Abstract
BACKGROUND: Autoantibodies to glutamic acid decarboxylase (GAD-A) are present in type 1 diabetes and stiff man syndrome (SMS), and have also been reported in cerebellar ataxia. Epilepsy was present in 4 of 19 patients with SMS and GAD-A, implying that epilepsy sometimes is associated with anti-GAD autoimmunity. METHODS: The authors investigated the prevalence of GAD-A in patients with therapy-resistant localization-related epilepsy (n = 51) and generalized epilepsy (n = 49) by a radiobinding assay. The positive samples were confirmed by immunohistochemistry and immunoblotting of recombinant human GAD65. RESULTS: GAD-A were found in eight patients with localization-related epilepsy, whereas none of the patients with generalized epilepsy, other neurologic disorders (n = 38), or the control subjects (n = 48) had GAD-A. Two patients had high levels of GAD-A, similar to SMS, whereas six patients had significantly lower titers, characteristic of type 1 diabetes. The two patients with high levels of GAD-A had GAD-A both in serum and CSF by immunohistochemistry and immunoblotting. Both of them had longstanding therapy-resistant temporal lobe epilepsy but did not have diabetes. One had a history of autoimmune disease, whereas the other had serologic evidence of multiple autoantibodies without any clinical signs of autoimmune disease. CONCLUSIONS: GAD autoimmunity may be associated with refractory localization-related epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autoantibodies to Glutamate Receptor GluR3 in Rasmussen's Encephalitis
Rogers, S. W., Andrews, P. I., Gahring, L. C., Whisenand, T., Cauley, K., Crain, B., Hughes, T. E., Heinemann, S. F., & McNamara, J. O. (1994) · Science · doi:10.1126/science.8036512 · Cited by 687
Autoantibodies to GABA-ergic Neurons and Pancreatic Beta Cells in Stiff-Man Syndrome
Solimena, M., Folli, F., Aparisi, R., Pozza, G., & De Camilli, P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222202 · Cited by 629
Regulation of γ‐Aminobutyric Acid Synthesis in the Brain
Martin, D. L., & Rimvall, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03165.x · Cited by 614
Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity
Bonifacio, E., Genovese, S., Braghi, S., Bazzigaluppi, E., Lampasona, Y., Bingley, P. J., Rogge, L., Pastore, M. R., Bognetti, E., Bottazzo, G. F., et al. (1995) · Diabetologia · doi:10.1007/s001250050358 · Cited by 179
Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children
Savola, K., Sabbah, E., Kulmala, P., Vähäsalo, P., Ilonen, J., & Knip, M. (1998) · Diabetologia · doi:10.1007/s001250051067 · Cited by 161
Self-citationButler, M. H., Solimena, M., Dirkx, R., Hayday, A., & De Camilli, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2097 · Cited by 159
The clinical significance of an autoimmune response against glutamic acid decarboxylase
Ellis, T. M., & Atkinson, M. A. (1996) · Nature Medicine · doi:10.1038/nm0296-148 · Cited by 131
Schmidli, R. S., Colman, P. G., & Bonifacio, E. E. (1995) · Diabetes · doi:10.2337/diab.44.6.636 · Cited by 131
Cited by
Saiz, A., Blanco, Y., Sabater, L., González, F., Bataller, L., Casamitjana, R., Ramió-Torrentà, L., & Graus, F. (2008) · Brain · doi:10.1093/brain/awn183 · Cited by 623
Self-citationSteriade, C., Britton, J., Dale, R. C., Gadoth, A., Irani, S. R., Linnoila, J., McKeon, A., Shao, X., Venegas, V., & Bien, C. G. (2020) · Epilepsia · doi:10.1111/epi.16571 · Cited by 265
Metadata
- Authors
- Peltola, J., Kulmala, P., Isojärvi, J., Saiz, A., Latvala, K., Palmio, J., Savola, K., Knip, M., Keränen, T., & Graus, F.
- Venue
- Neurology
- Published
- 2000-07-12
- Volume
- 55
- Issue
- 1
- Pages
- 46-50
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2002377344
- Cited by
- 296
- References
- 13
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. https://app.cochat.ai/papers/10.1212/wnl.55.1.46
- The paper
- Peltola, J., Kulmala, P., Isojärvi, J., Saiz, A., Latvala, K., Palmio, J., Savola, K., Knip, M., Keränen, T., & Graus, F. (2000). Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology. https://doi.org/10.1212/wnl.55.1.46
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.